Search for: "Eli Lilly " Results 841 - 860 of 2,131
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Jan 2014, 2:15 pm by Gene Quinn
'With the U.S. patent expiration of Cymbalta last December and that of Evista coming in March, we expect 2014 to be the most financially challenging year of Lilly's current period of patent expirations,' said Derica Rice, Lilly executive vice president, global services and chief financial officer. [read post]
7 Jan 2014, 2:15 pm by Gene Quinn
'With the U.S. patent expiration of Cymbalta last December and that of Evista coming in March, we expect 2014 to be the most financially challenging year of Lilly's current period of patent expirations,' said Derica Rice, Lilly executive vice president, global services and chief financial officer. [read post]
7 Jan 2014, 7:46 am by Charles Kotuby
See, e.g, In re Eli Lilly & Co., No. 3:09MC296 (AWT), 2010 WL 2509133, at *4 (D. [read post]
2 Jan 2014, 2:08 am
in "Bilateral Investment Treaties: Claiming Compensation from Foreign Governments under Bilateral Investment Treaties for failing to provide adequate IP Protection" 27 July 2013 I mentioned a possible claim by the US company Eli Lilly & Co. against the Canadian government under Chapter II of the agreement between the US, Canadian and Mexican governments establishing the North America Free Trade [read post]
27 Dec 2013, 8:44 am
Eli Lilly & Co., No. 0:13-591-CMC, 2013 U.S. [read post]
27 Dec 2013, 1:27 am
* Despite its apparent logic, Eli Lilly's application was logically incoherent. [read post]
18 Dec 2013, 2:32 am
An FDA spokesman told The Times that so far, the agency has received commitments to follow the plan from two major drug producers, former Pfizer subsidiary Zoetis and Elanco, which is owned by Eli Lilly & Co. [read post]
16 Dec 2013, 1:23 pm
Similarly in Actavis v Eli Lilly [2013] EWCA Civ 517, the Court of Appeal confirmed that the English courts have jurisdiction to hear claims for declarations of non-infringement in relation to foreign designations of European patents where there is no challenge to validity. [read post]
12 Dec 2013, 7:12 am
In short, where the patent holder has already obtained an SPC on the basis of a patent protecting an innovative active ingredient and a marketing authorisation for a medicinal product containing that ingredient as the single active ingredient, and that SPC entitles him to oppose the use of that active ingredient, either alone or in combination with other active ingredients, Article 3(c) of the SPC Regulation must be interpreted as precluding that patent holder from obtaining –- on the basis of… [read post]
9 Dec 2013, 7:06 am by Rebecca Tushnet
Eli Lilly and Co., 2013 WL 6345442, No. 2:12–cv–9366 (C.D. [read post]
3 Dec 2013, 3:10 am
Eli Lilly, of course, believes the cost of the test should be covered without restriction. [read post]
30 Nov 2013, 12:37 pm by Howard Knopf
Among other things, he provides frank, wise,and often witty remarks on:leave applications, including the recent rare example of oral argument in the Eli Lilly casethe use of a "glossary" in factumsthe dangers of using disrespectful rhetoricthe relative importance of written arguments and some very good tips on how to write themthe recent development of a conference amongst the judges 15 minutes before the hearingthe recent changes in intervener factum lengths and time limitssome… [read post]
27 Nov 2013, 6:00 am
Indianapolis, Indiana - Eli Lilly and Company of Indianapolis, Indiana; Eli Lilly Export S.A. of Geneva, Switzerland (collectively, "Lilly"); and Acrux DDS Pty Ltd. of West Melbourne, Australia have filed a patent infringement lawsuit in the Southern District of Indiana alleging that Actavis, Inc. and Actavis Pharma, Inc., both of Parsippany, New Jersey, and Watson Laboratories, Inc. of Corona, California infringed Patent Nos. 6,299,900 - Dermal… [read post]
25 Nov 2013, 6:00 am
Indianapolis, Indiana - Eli Lilly and Company of Indianapolis, Indiana has filed a trademark infringement lawsuit in the Southern District of Indiana alleging that Sebastian Wiradharma a/k/a Sebastian Singh ("Singh") and Singpet Pte. [read post]
20 Nov 2013, 9:35 pm by Aaron Barkoff
Eli Lilly and Co., IPR2013-00356 (a second complaint in the second of two prior lawsuits did not reset the time for filing a petition); St. [read post]
20 Nov 2013, 6:23 am
Indianapolis, Indiana - Eli Lilly and Company of Indianapolis, Indiana ("Lilly") has filed a trademark infringement lawsuit in the Southern District of Indiana alleging that Graham Nelson, Zoja Pty Ltd. d/b/a Pet Supply International Ltd., and Pet Products Net, all of Australia, infringed the trademark COMFORTIS, Trademark Registration No. 3,370,168, which has been registered by the U.S. [read post]
18 Nov 2013, 11:40 am by Gene Quinn
Eli Lilly and Company and Acrux DDS Pty Ltd. filed suit against Actavis on November 12, 2013, in the U.S. [read post]
17 Nov 2013, 8:56 pm by Patent Docs
Ltd.; Eli Lilly Export S.A. [read post]